AJU IB Investment Co., Ltd. - Q3 2022 holdings

$58.4 Million is the total value of AJU IB Investment Co., Ltd.'s 7 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 0.0% .

 Value Shares↓ Weighting
 ARCELLX INC$25,919,000
+3.8%
1,380,8900.0%44.37%
-8.2%
 RALLYBIO CORP$10,920,000
+91.6%
754,6780.0%18.69%
+69.5%
KYMR  KYMERA THERAPEUTICS INC$9,950,000
+10.6%
457,0590.0%17.03%
-2.2%
SEER  SEER INC$6,319,000
-13.5%
816,3750.0%10.82%
-23.5%
RAPT  RAPT THERAPEUTICS INC$2,394,000
+31.8%
99,5030.0%4.10%
+16.6%
 XILIO THERAPEUTICS INC$1,943,000
-0.4%
667,7420.0%3.33%
-11.9%
STRO  SUTRO BIOPHARMA INC$971,000
+6.5%
175,0000.0%1.66%
-5.9%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR/A filed 2022-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
KYMERA THERAPEUTICS INC8Q3 202240.4%
SEER INC8Q3 202225.9%
RAPT THERAPEUTICS INC8Q3 20225.1%
SUTRO BIOPHARMA INC8Q3 20223.6%
ATEA PHARMACEUTICALS INC4Q3 202147.7%
APELLIS PHARMACEUTICALS INC4Q3 202138.8%
RALLYBIO CORP4Q3 202218.7%
XILIO THERAPEUTICS INC4Q3 202214.9%
CLEARSIDE BIOMEDICAL INC4Q3 20211.1%
MOLECULAR TEMPLATES INC4Q3 20211.0%

View AJU IB Investment Co., Ltd.'s complete holdings history.

Latest filings
TypeFiled
13F-HR/A2022-11-14
13F-HR2022-11-07
13F-HR2022-08-09
13F-HR2022-05-12
13F-HR2022-02-09
13F-HR2021-11-10
13F-HR2021-08-10
13F-HR2021-05-12
13F-HR2021-05-12
42017-11-13

View AJU IB Investment Co., Ltd.'s complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported has been restated
  • The reported has been amended

Export AJU IB Investment Co., Ltd.'s holdings